Intellia Therapeutics, Inc. (NTLA)
12.82
+0.32
(+2.56%)
USD |
NASDAQ |
Jan 20, 15:01
Intellia Therapeutics Accounts Receivable (Quarterly): 11.05M for Sept. 30, 2025
Accounts Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -- |
| ANI Pharmaceuticals, Inc. | 252.62M |
| Regeneron Pharmaceuticals, Inc. | 5.687B |
| Pacific Biosciences of California, Inc. | 30.62M |
| Twist Bioscience Corp. | 57.02M |